PMC:7402624 / 11189-11449
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T58","span":{"begin":19,"end":24},"obj":"Body_part"},{"id":"T59","span":{"begin":211,"end":216},"obj":"Body_part"}],"attributes":[{"id":"A58","pred":"fma_id","subj":"T58","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A59","pred":"fma_id","subj":"T59","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"302","span":{"begin":13,"end":16},"obj":"Gene"},{"id":"303","span":{"begin":205,"end":208},"obj":"Gene"},{"id":"316","span":{"begin":122,"end":133},"obj":"Disease"},{"id":"317","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"Gene:920"},{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"Gene:925"},{"id":"A316","pred":"tao:has_database_id","subj":"316","obj":"MESH:D008231"},{"id":"A317","pred":"tao:has_database_id","subj":"317","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T84","span":{"begin":122,"end":133},"obj":"Disease"},{"id":"T85","span":{"begin":141,"end":149},"obj":"Disease"}],"attributes":[{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T127","span":{"begin":13,"end":16},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T128","span":{"begin":17,"end":24},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T129","span":{"begin":180,"end":181},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T130","span":{"begin":205,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T131","span":{"begin":209,"end":216},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":122,"end":133},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T75","span":{"begin":67,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}
2_test
{"project":"2_test","denotations":[{"id":"32669297-32217835-135105197","span":{"begin":159,"end":161},"obj":"32217835"},{"id":"32669297-32376308-135105197","span":{"begin":159,"end":161},"obj":"32376308"},{"id":"32669297-32296069-135105197","span":{"begin":159,"end":161},"obj":"32296069"},{"id":"32669297-31986264-135105197","span":{"begin":159,"end":161},"obj":"31986264"}],"text":"al) than for CD4 T cells (38/61 subjects below normal) (fig. S1E). These findings are consistent with previous reports of lymphopenia during COVID-19 disease (17–20) but highlight a preferential impact on CD8 T cells.\nWe next asked if the changes in these lymp"}